For patients here in the commonwealth and across the country, we’re on the cusp of a new era in cancer care — one that could ...

Patented platform uses cell-free DNA analysis and machine learning to detect cancer early and identify tissue of origin from ...

The patented platform combines genome sequencing, methylation analysis and machine learning to detect cancer and identify its ...

Reliance's Strand Life Sciences secures Indian patent for blood-based early cancer detection technology ...

A machine learning program that identified patients overdue for colorectal cancer screening helped increase screening rates ...

Reliance’s Strand Life Sciences patents a blood-based technology for early cancer detection, enhancing accuracy and accessibility.

In a significant breakthrough for cancer diagnostics, Reliance Industries subsidiary Strand Life Sciences has secured an Indian patent for an artificial intelligence-powered technology that can detect ...

Multiomics data integration with machine learning has become the standard approach for combining genomic, transcriptomic, proteomic, and metabolomic measurements collected from the same biological ...

Colorectal cancer is associated with certain microbiomes that produce microbial signatures that can be detected by a ...

Oncology innovation is reshaping cancer care as AI, immunotherapy and targeted therapies fuel pipeline growth and spotlight ...

We're on the cusp of a new era in cancer care – one that could dramatically improve survival and quality of life.

Reliance's Strand Life Sciences patents a liquid biopsy platform for early cancer detection using AI and cfDNA analysis in ...